Related Experiment Video
Updated: Apr 26, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Nicotine Pouch Use Among U.S. Adults in 2023 and 2024
Yi-Chun Chang1, Megan E Patrick2, Yvonne M Terry-McElrath2
1Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California; Institute for Addiction Science, University of Southern California, Los Angeles, California.
Introduction:
Recent expansion of U.S. nicotine pouch marketing may increase nicotine pouch use. This study estimated U.S. adult pouch use during 2023-2024 overall and across sociodemographic, cigarette smoking, nicotine vaping, and non-nicotine substance use subgroups.
Methods:
Data were drawn from the nationally representative Monitoring the Future longitudinal panel 2023 and 2024 surveys (N=15,340; ages 19-65 years; 59.6% response rate conditional on Wave 1; analyzed in 2025-2026). Past 12-month and past 30-day nicotine pouch use prevalence was estimated each year in the overall sample and stratified by sociodemographic and substance use status.
Results:
In the overall sample, prevalence increased from 2023 to 2024 for past 12-month (3.4%-5.9%; prevalence ratio=1.75, 95% CI=1.45, 2.13) and past 30-day (2.3%-4.2%; prevalence ratio=1.81, 95% CI=1.44, 2.27) use. Increases in past 12-month prevalence were observed across ages, sexes, and geographies and among non-Hispanic White adults. Past-12-month and past-30-day prevalences increased during 2023-2024 among adults with no past-12-month smoking, never or former vaping, current smoking, with and without current alcohol or cannabis use, and without current other non-nicotine substance use (PRs range:1.53-3.10). No significant cross-year change was observed among those with current vaping, current other non-nicotine substance use, or recent former smoking. Within-year comparisons showed a higher 2024 past 12-month prevalence among young than among older adults, males than females, non-Hispanic White than Black adults, individuals with recent smoking or vaping than those without, and those with current non-nicotine substance use than those without.
Conclusions:
U.S. adult nicotine pouch use increased from 2023 to 2024 across sociodemographic and nicotine/tobacco use statuses. Further population-level surveillance and longitudinal research on pouch use patterns are warranted.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Drug Dependence
Oral Drug Delivery Systems: Continuous-Release Systems